Skip to content

Clinical trials

Phase 2 Albuminuria trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Albuminuria Phase: Phase 2 Country / region: United States Clear all

15 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20061
20082
20111
20121
20133
20151
20171
20191
20221
20231
20241
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed12
Recruiting2
Terminated1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
University of North Carolina, Chapel Hill2
Ardelyx1
AstraZeneca1
Calliditas Therapeutics AB1
InVasc Therapeutics, Inc.1
Mineralys Therapeutics Inc.1
Novartis Pharmaceuticals1
Pfizer1
Symphony Evolution, Inc.1
University Medical Center Groningen1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Albuminuria15
Diabetes Mellitus, Type 25
Diabetic Nephropathies5
Renal Insufficiency, Chronic5
Anemia, Sickle Cell3
Hypertension2
Kidney Diseases2
Proteinuria2
Diabetes Mellitus1
Heart Failure1

Trials

Showing 1 to 15 of 15. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.